Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint proteins are associated with persistently high liver stiffness after successful HCV treatment in people with HIV: a retrospective study.
Martín-Escolano R, Virseda-Berdices A, Berenguer J, González-García J, Brochado-Kith O, Fernández-Rodríguez A, Díez C, Hontañon V, Resino S, Jiménez-Sousa MÁ. Martín-Escolano R, et al. Among authors: gonzalez garcia j. Front Immunol. 2024 Dec 17;15:1505864. doi: 10.3389/fimmu.2024.1505864. eCollection 2024. Front Immunol. 2024. PMID: 39742264 Free PMC article.
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.
Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S; GESIDA 3603b Study Group. Medrano LM, et al. AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787. AIDS. 2018. PMID: 29438197
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study.
Garcia-Broncano P, Medrano LM, Berenguer J, Brochado-Kith O, González-García J, Jiménez-Sousa MÁ, Quereda C, Sanz J, Téllez MJ, Díaz L, JIménez JL, Resino S; GESIDA 3603b Study Group. Garcia-Broncano P, et al. J Infect. 2020 Jan;80(1):99-110. doi: 10.1016/j.jinf.2019.09.020. Epub 2019 Oct 1. J Infect. 2020. PMID: 31585189
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients.
Carrero A, Berenguer J, Hontañón V, Navarro J, Hernández-Quero J, Galindo MJ, Quereda C, Santos I, Téllez MJ, Ortega E, Sanz J, Medrano LM, Pérez-Latorre L, Bellón JM, Resino S, Bermejo J, González-García J; GeSIDA 3603b Study Group. Carrero A, et al. J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):292-300. doi: 10.1097/QAI.0000000000002260. J Acquir Immune Defic Syndr. 2020. PMID: 31913996
Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis.
Díez C, Berenguer J, Ibañez-Samaniego L, Llop E, Pérez-Latorre L, Catalina MV, Hontañón V, Jiménez-Sousa MA, Aldámiz-Echevarría T, Martínez J, Calleja JL, Albillos A, Bellón JM, Resino S, González-García J, Bañares R. Díez C, et al. Clin Infect Dis. 2020 Dec 17;71(10):2726-2729. doi: 10.1093/cid/ciaa502. Clin Infect Dis. 2020. PMID: 32386053
Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients.
Salgüero S, Rojo D, Berenguer J, González-García J, Fernández-Rodríguez A, Brochado-Kith O, Díez C, Hontañon V, Virseda-Berdices A, Martínez J, Ibañez-Samaniego L, Llop-Herrera E, Barbas C, Resino S, Jiménez-Sousa MA; Escorial Study Group. Salgüero S, et al. Liver Int. 2020 Sep;40(9):2215-2227. doi: 10.1111/liv.14580. Epub 2020 Jul 7. Liver Int. 2020. PMID: 32593189
Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study.
Medrano LM, Berenguer J, Salgüero S, González-García J, Díez C, Hontañón V, Garcia-Broncano P, Ibañez-Samaniego L, Bellón JM, Jiménez-Sousa MA, Resino S. Medrano LM, et al. Front Med (Lausanne). 2021 Feb 1;8:615342. doi: 10.3389/fmed.2021.615342. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33598470 Free PMC article.
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.
Brochado Ó, Martínez I, Berenguer J, Medrano L, González-García J, Jiménez-Sousa MÁ, Carrero A, Hontañón V, Navarro J, Guardiola JM, Fernández-Rodríguez A, Resino S; GESIDA Study Group. Brochado Ó, et al. J Biomed Sci. 2021 Mar 30;28(1):23. doi: 10.1186/s12929-021-00718-6. J Biomed Sci. 2021. PMID: 33785040 Free PMC article.
626 results